Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$54.21 - $70.44 $249,366 - $324,024
4,600 New
4,600 $0
Q1 2022

Apr 14, 2022

SELL
$55.72 - $67.12 $729,932 - $879,272
-13,100 Closed
0 $0
Q4 2021

Jan 10, 2022

SELL
$54.02 - $63.83 $135,050 - $159,575
-2,500 Reduced 16.03%
13,100 $24,000
Q3 2021

Oct 14, 2021

SELL
$55.56 - $60.79 $200,016 - $218,844
-3,600 Reduced 18.75%
15,600 $53,000
Q2 2021

Jul 26, 2021

SELL
$48.42 - $60.18 $1.43 Million - $1.78 Million
-29,600 Reduced 60.66%
19,200 $143,000
Q1 2021

Apr 29, 2021

BUY
$47.16 - $54.44 $622,512 - $718,608
13,200 Added 37.08%
48,800 $40,000
Q4 2020

Jan 13, 2021

BUY
$48.52 - $58.02 $713,244 - $852,894
14,700 Added 70.33%
35,600 $51,000
Q3 2020

Oct 28, 2020

BUY
$53.07 - $61.1 $403,332 - $464,360
7,600 Added 57.14%
20,900 $31,000
Q4 2019

Jan 06, 2020

BUY
$42.46 - $50.46 $101,904 - $121,104
2,400 Added 22.02%
13,300 $82,000
Q3 2019

Oct 03, 2019

SELL
$40.12 - $45.47 $324,972 - $368,307
-8,100 Reduced 42.63%
10,900 $40,000
Q2 2019

Jul 10, 2019

SELL
$37.28 - $41.68 $104,384 - $116,704
-2,800 Reduced 12.84%
19,000 $52,000
Q1 2019

Apr 08, 2019

BUY
$35.49 - $43.02 $773,682 - $937,836
21,800 New
21,800 $60,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.